Activities of Mireille D'ORNANO related to 2018/2774(RSP)
Plenary speeches (1)
Lyme disease (Borreliosis) (debate) FR
Institutional motions (1)
MOTION FOR A RESOLUTION on Lyme disease (Borreliosis) PDF (268 KB) DOC (55 KB)
Oral questions (1)
Lyme disease (borreliosis) PDF (95 KB) DOC (18 KB)
Amendments (13)
Amendment 1 #
Citation 1 a (new)
- having regard to Article 168(7) of the Treaty on the Functioning of the European Union, under which responsibility for the organisation and delivery of health services and medical care lies with the Member States;
Amendment 3 #
Recital A a (new)
Amendment 9 #
Recital F a (new)
Fa. whereas the European Centre for Disease Prevention and Control (ECDC) has not been mandated to find cures for certain diseases but has nevertheless collected information from Member States in order to better understand the epidemiology of Lyme disease and has published recommendations for health professionals, as the infection is sometimes difficult to diagnose;
Amendment 10 #
Recital F b (new)
Fb. whereas this is not enough, however, because many doctors are unable to make a relevant diagnosis owing to the wide variety of possible symptoms, the best known being erythema migrans – an annular rash around the bite area – joint pain and fatigue, which can lead to misdiagnosis as a result of confusion with lupus, viral infections, multiple sclerosis or fibromyalgia.
Amendment 14 #
Recital J a (new)
Ja. whereas the Commission has stated, in Mr Andriukaitis's answer to written question E-002453/2017 of 2 June 2017, that it does not intend to launch a large-scale enquiry into Lyme disease and the issue of cross border movement of patients to receive treatment;
Amendment 15 #
Recital J b (new)
Jb. whereas the Commission has stated that it does not systematically collect information on the screening methods or on treatments administered in the Member States;
Amendment 17 #
Recital O a (new)
Oa. whereas Lyme disease remains very difficult to diagnose given that the infection does not manifest itself until 7 to 14 days after the tick bite, the skin reaction around the bite eventually disappears and a wide variety of symptoms may appear, thus making it difficult to establish a link with Lyme disease;
Amendment 18 #
Recital P a (new)
Pa. whereas a number of serological tests have been strongly criticised for their unreliability, with some subjects suffering from often highly debilitating symptoms declared negative, and thus find themselves misdiagnosed and deprived of the antibiotic treatments needed to combat the disease; whereas numerous complaints have also been lodged against the manufacturers of diagnostic tests and that some doctors have been criticised for offering unconventional tests and treatments;
Amendment 20 #
Recital Q a (new)
Qa. whereas since 2007 the EU has contributed a total of EUR 33.9 million to Lyme disease research and the European Investment Bank has recently granted a EUR 25 million loan for the development of a vaccine against Lyme disease;
Amendment 27 #
Paragraph 10 a (new)
10a. Encourages the Commission to publish guidelines on the reliability of serological tests and unconventional treatments for Lyme disease;
Amendment 34 #
Paragraph 16 a (new)
16a. Calls on the Commission to promote public awareness-raising campaigns on the risks of contracting Lyme disease following tick bites and in particular of the fact that the infection manifests itself some time after a tick bite and with a wide variety of symptoms;
Amendment 37 #
Paragraph 18 a (new)
18a. Invites the Commission to assess the extent of the phenomenon of misdiagnosis affecting certain patients and in particular the cross-border movement of patients seeking treatment;
Amendment 39 #
Paragraph 18 b (new)
18b. Calls on the Commission to inform the Member States in full transparency of the scientific outcome of the many millions invested in research into Lyme disease and the development of a vaccine against it;